Study S001392

Timely Detection of Treatment Emergent Serious and Non-serious Adverse Events for Saxenda® in Mexican Patients

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02773355
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 27
Start: 2016-05-16
Primary completion: 2021-11-30
Lead sponsor: Novo Nordisk A/S
Conditions: Obesity
Interventions: DRUG:liraglutide 3.0 mg
Results posted: FALSE
Secondary identifiers: OTHER:U1111-1170-6497

Registered primary outcomes

Frequency of pancreatitis [Year 0-3]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.